C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 307/81 (2006.01) A61K 31/343 (2006.01) A61P 25/16 (2006.01) A61P 25/18 (2006.01) A61P 25/24 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2317036
Novel compounds involving optically pure (-)1-(benzofuran-2-yl)-2- propylaminopentane represented by formula (I), which is substantially free from the (+)-isomer and pharmacologically acceptable acid addition salts thereof. Because of being excellent in the effect of regulatively enhancing neurotransmitters catecholamines (i.e., CAE (Catecholaminergic Activity Enhancer) effect), these compounds are useful as psychotropic drugs and remedies for Parkinson's disease, depression and Alzheimer's disease.
Nouveaux composés contenant (-)-1-(benzofurane-2-yl)-2-propylaminopentane représentés par la formule (I) sensiblement exempte de l'isomère (+), ainsi que leur sels d'apport acide acceptables sur le plan pharmacologique: Etant donné qu'ils exercent un effet excellent sur l'augmentation de la régulation des catécholamines de neurotransmetteurs (i.e., CAE amplificateur de l'activité catécholaminergique), ces composés sont utiles en tant queédicaments psychotropes et remèdes contre les maladie de Parkinson, la dépression et la maladie d'Alzheimer.
Ando Takashi
Knoll Joseph
Moto Toshiaki
Ohde Hironori
Sakae Masatoshi
Fujimoto Brothers Co. Ltd.
Fujimoto Co. Ltd.
Marks & Clerk
LandOfFree
Novel optically active aminopentane derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel optically active aminopentane derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel optically active aminopentane derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1693977